CU Anschutz
Academic Office One
12631 East 17th Avenue
4th Floor
Aurora, CO 80045
Press Coverage Community Women's Health
For the first time since its debut in 1960 – when some states still outlawed contraceptive use for married couples – a birth control pill has been approved for purchase without a prescription and should be available at neighborhood drugstore shelves any day now.
Research Press Releases Gynecologic Cancer Endometrial Cancer
The results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer new hope to patients with metastatic and recurrent uterine cancer, also known as endometrial cancer.
Research Patient Care Gynecologic Cancer Ovarian Cancer
A team of researchers at the University of Colorado Anschutz Medical Campus has gained attention for its work on rethinking ovarian cancer disease progression and treatment. Equipped with highly advanced technology, they are making inroads in rendering the most lethal cancer of the female reproductive system less deadly.
At birth, ovaries in girls can contain about a million tiny structures called primordial follicles, each of which contains an egg cell. As girls grow and experience adulthood, most of these follicles will die while only one follicle will survive each month to ovulate a mature egg. When the loss of primordial follicles is nearly complete, and only hundreds remain, women reach menopause, a time when menstrual cycles have ceased for 12 months.
A new “report card” on maternal and infant health from the March of Dimes gives Colorado a “C” grade for its rate of preterm births. And while that’s a slightly higher mark than the “D+” grade the national nonprofit group gives to the nation as a whole, the Colorado report is studded with concerning data points about the state.
Research Gynecologic Cancer Magazine Ovarian Cancer
Ovarian cancer is a growing area of research at the University of Colorado Cancer Center. A newly formed Ovarian Cancer Innovations Group, envisioned by Saketh Guntupalli, MD, and led by Kian Behbakht, MD, MBA, is taking a multipronged approach to studying the disease.
A pair of University of Colorado Cancer Center researchers have received a major grant to fund the next five years of their long-running research into a genetic risk factor for ovarian cancer that varies greatly across different ethnic communities – research that they hope will lead to better-targeted therapies.
Patient Care Magazine Ovarian Cancer
Amy Bibbey has two distinct lives. There’s the life she led before ovarian cancer, and there’s everything after diagnosis.
Research Ovarian Cancer Multiple Myeloma
Many of the side effects of cancer treatment are well-known, including nausea, fatigue, and weight loss.
At least one in four women suffer with pelvic floor disorder symptoms that can range from urine leakage to organs falling out of place, sometimes protruding outside the vagina. Many women remain silent, embarrassed to share their issues even with their doctors.
Patient Care Ovarian Cancer Immunotherapy Genetics
People often tell Winona Williams that she’s brave, and she is. Ovarian cancer could easily become a dark cloud over her, shadowing every minute of every day.
Affected patients describe being gripped by “profound sadness” or “paralyzed” by bouts of anxiety and exhaustion. The feelings of perinatal mood disorders, which often result in a sense of hopelessness, strike mothers during what should be one of the happiest times of their lives.
Research Cancer Ovarian Cancer
One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.
In two recent articles published in Schizophrenia Bulletin, Sharon Hunter, PhD, an associate professor in the University of Colorado School of Medicine Department of Psychiatry, and M. Camille Hoffman, MD, MSc, an associate professor in the University of Colorado School of Medicine Department of Obstetrics and Gynecology, along with their research group, have uncovered a potential link between choline deficiency in Black pregnant women in the United States and increased risk of developmental and behavioral issues that can evolve into mental illness later in their children’s lives.
After seeing the tragic COVID-19 crisis unfolding in India, Saketh Guntupalli, MD, associate professor of gynecologic oncology in the University of Colorado School of Medicine and member of the University of Colorado Cancer Center, decided to do something about it.
Gynecologic Cancer Vaccinations Cervical Cancer
January is Cervical Cancer Awareness Month, and CU Cancer Center member Lindsay Brubaker, MD, wants everyone to be aware of the relationship between cervical cancer and the human papillomavirus (HPV), a sexually-transmitted disease that causes the vast majority of cervical cancers. The current HPV vaccine protects against seven predominant strains of the virus that cause cancer, as well as the two that cause genital warts.
Diabetes Public Health Women's Health
Researchers at the University of Colorado Anschutz Medical Campus have discovered a direct association between placental function in pregnant women and future metabolic disorders in children and adults, a finding that could lead to earlier intervention and diagnosis of disease.
Research Patient Care Press Releases
A study of Catholic obstetrician-gynecologists shows some face moral dilemmas when dealing with issues of family planning and abortion due to their religious faith, according researchers at the University of Colorado Anschutz Medical Campus.
Research Gynecologic Cancer Ovarian Cancer
After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.
Research Gynecologic Cancer Cervical Cancer
Last month the American Cancer Society (ACS) released updated guidelines for cervical cancer screening. The most notable change in guidelines is the changes in the age to begin screening. Per the new guidelines, it is recommended that cervical cancer screening begin at age 25. Previously, the starting age for screening was 21.
As survival rates of many common cancers have improved it is no surprise that conversations around fertility preservation have also increased. These advances in treatments are letting patients think about their future beyond cancer, and if that future includes children.
Philanthropy Gynecologic Cancer Cancer Ovarian Cancer
In July 2019, Emily McClintock Addlesperger was on vacation in Maine with her husband, Jason, when she felt sick and was airlifted to Portland with internal bleeding. A tumor on her ovary had burst. It was Monday. On Saturday, she passed away. Emily was 44 years old.
Pregnant women who take extra choline supplements may mitigate the negative impact that viral respiratory infections, including COVID-19, can have on their babies, according to a new study from researchers in the Departments of Psychiatry and Obstetrics and Gynecology at the University of Colorado Anschutz Medical Campus. Choline is a vitamin B nutrient found in various foods and dietary supplements, and is critical to fetal brain development.
Research Patient Care Press Releases
A small minority of Americans surveyed consider the religious affiliation of the hospitals that treat them, but a majority said they didn’t want religious doctrine dictating their healthcare choices, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
Department of Obstetrics and Gynecology
12631 East 17th Avenue
4th Floor
Aurora, CO 80045
303-724-2041
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.